desvenlafaxine succinate

FDA Drug Profile — desvenlafaxine, Pristiq Extended-Release

Drug Details

Generic Name
desvenlafaxine succinate
Brand Names
desvenlafaxine, Pristiq Extended-Release
Application Number
ANDA204003
Sponsor
Pfizer Asia Manufacturing Pte Ltd
NDC Codes
8
Dosage Forms
POWDER, TABLET, EXTENDED RELEASE
Routes
ORAL
Active Ingredients
DESVENLAFAXINE SUCCINATE

Indications and Usage

1 INDICATIONS AND USAGE Desvenlafaxine is indicated for the treatment of adults with major depressive disorder (MDD) [see Clinical Studies (14)] . Desvenlafaxine is a serotonin and norepinephrine reuptake inhibitor (SNRI) indicated for the treatment of adults with major depressive disorder (MDD) ( 1 ).